G1 Therapeutics News

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thomas Monica R.

May 24 15:19

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perry Andrew

May 15 21:24

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MURDOCK TERRY L

May 15 21:24

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bailey John E. (Jack) Jr.

May 15 16:14

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Malik Rajesh

May 15 16:01

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

May 15 15:21

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Avagliano Mark

May 15 15:18

G1 Therapeutics | 10-Q: Quarterly report

May 1 15:25

G1 Therapeutics | 8-K: Current report

May 1 05:44

G1 Therapeutics | ARS: Annual Report to Security Holders

Apr 25 15:21

G1 Therapeutics | DEF 14A: Definitive information statements

Apr 25 15:18

G1 Therapeutics | DEFA14A: Others

Apr 25 15:17

G1 Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 15:14

G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 9 15:31

G1 Therapeutics | 8-K: Current report

Mar 22 15:19

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Avagliano Mark

Mar 22 15:14

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thomas Monica R.

Mar 22 15:13

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

Mar 22 15:13

G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V

Mar 20 15:33

G1 Therapeutics | 10-K: Annual report

Feb 28 21:28